Moreover, as observed in the SCCHN PDTX models, prolonged exposure to cetuximab (three weeks) induced downregulation of the level of Rb protein expression in the two SCCHN cell lines, as compared to the controls (Figure 3 and Figure 4). The gene discussed is RB1; the disease is head and neck squamous cell carcinoma.